Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Daniel J Zabransky"'
Autor:
Laura Hüser, Yash Chhabra, Olesia Gololobova, Vania Wang, Guanshu Liu, Agrani Dixit, Murilo Ramos Rocha, Elizabeth I. Harper, Mitchell E. Fane, Gloria E. Marino-Bravante, Daniel J. Zabransky, Kathy Q. Cai, Jochen Utikal, Barbara S. Slusher, Jeremy Walston, Evan J. Lipson, Kenneth W. Witwer, Ashani T. Weeraratna
Publikováno v:
Cell Reports, Vol 43, Iss 9, Pp 114721- (2024)
Summary: Advancing age is a negative prognostic factor for cutaneous melanoma. However, the role of extracellular vesicles (EVs) within the melanoma tumor microenvironment (TME) has remained unexplored in the context of aging. While the size and morp
Externí odkaz:
https://doaj.org/article/cc61c2bf190f43668f9e6e6022b1b7fe
Autor:
Daniel J Zabransky, Christopher J Nirschl, Nicholas M Durham, Ben V Park, Christina M Ceccato, Tullia C Bruno, Ada J Tam, Derese Getnet, Charles G Drake
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34547 (2012)
Helios, an Ikaros family transcription factor, is preferentially expressed at the mRNA and protein level in regulatory T cells. Helios expression previously appeared to be restricted to thymic-derived Treg. Consistent with recent data, we show here t
Externí odkaz:
https://doaj.org/article/bf78dfb5507b46cb832b8fcb32d0ddc4
Autor:
Rachid Sougrat, Alberto Bartesaghi, Jeffrey D Lifson, Adam E Bennett, Julian W Bess, Daniel J Zabransky, Sriram Subramaniam
Publikováno v:
PLoS Pathogens, Vol 3, Iss 5, p e63 (2007)
The envelope glycoproteins of primate lentiviruses, including human and simian immunodeficiency viruses (HIV and SIV), are heterodimers of a transmembrane glycoprotein (usually gp41), and a surface glycoprotein (gp120), which binds CD4 on target cell
Externí odkaz:
https://doaj.org/article/36cf1d5d48fa4e7a94a9d05b258e5182
Publikováno v:
Annual Review of Cancer Biology. 7:149-170
Immune checkpoint inhibitors induce significant and durable treatment responses in about 20% of all cancers, but many patients have natural resistance to current immunotherapies. The past decade of technological advances has resulted in large-scale p
Autor:
Mitchell E. Fane, Yash Chhabra, Gretchen M. Alicea, Devon A. Maranto, Stephen M. Douglass, Marie R. Webster, Vito W. Rebecca, Gloria E. Marino, Filipe Almeida, Brett L. Ecker, Daniel J. Zabransky, Laura Hüser, Thomas Beer, Hsin-Yao Tang, Andrew Kossenkov, Meenhard Herlyn, David W. Speicher, Wei Xu, Xiaowei Xu, Elizabeth M. Jaffee, Julio A. Aguirre-Ghiso, Ashani T. Weeraratna
Publikováno v:
Nature
Disseminated cancer cells from primary tumours can seed in distal tissues, but may take several years to form overt metastases, a phenomenon that is termed tumour dormancy. Despite its importance in metastasis and residual disease, few studies have b
Autor:
Daniel J. Zabransky, Ludmila Danilova, James M. Leatherman, Tamara Y. Lopez‐Vidal, Jessica Sanchez, Soren Charmsaz, Nicole E. Gross, Sarah Shin, Xuan Yuan, Alexei Hernandez, Hongqui Yang, Stephanie Xavier, Daniel Shu, Ali Saeed, Kabeer Munjal, Zeal Kamdar, Luciane T. Kagohara, Elizabeth M. Jaffee, Mark Yarchoan, Won Jin Ho
Publikováno v:
Hepatology
BACKGROUND AND AIMS: The treatment of hepatocellular carcinoma (HCC) has been transformed by the use of immune checkpoint inhibitors. However, most patients with HCC do not benefit from treatment with immunotherapy. There is an urgent need to underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8d8e5bded14d7bc88afdbe64239061
https://europepmc.org/articles/PMC9905363/
https://europepmc.org/articles/PMC9905363/
Autor:
Ashley Cimino-Mathews, Sarah J. Wheelan, Ben H. Park, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, David Chu, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Daniel J. Zabransky, Christopher D. Gocke, Katie Beierl, Bracha Erlanger Avigdor
Supplemental figure S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87977eeda8d410c46b5d06f4d8a8ad60
https://doi.org/10.1158/1078-0432.22462719.v1
https://doi.org/10.1158/1078-0432.22462719.v1
Autor:
Ben H. Park, Vered Stearns, Jane Zorzi, Zhe Zhang, Daniel J. Zabransky, Lauren E. Young, Antonio C. Wolff, Dustin A. VanDenBerg, Philip J. Stephens, Shannon Slater, Jeffrey S. Ross, Gary L. Rosner, Geoff A. Otto, Vincent A. Miller, Doron Lipson, Justin Lee, Josh Lauring, Mark R. Kennedy, Stacie C. Jeter, Christopher D. Gocke, Travis A. Clark, Sarah Croessmann, Rory L. Cochran, Roisin M. Connolly, David Chu, Jennifer Axilbund, Siraj M. Ali, Ashley Cimino-Mathews, Julia A. Beaver, Heather A. Parsons
Purpose: The clinical utility of next-generation sequencing (NGS) in breast cancer has not been demonstrated. We hypothesized that we could perform NGS of a new biopsy from patients with metastatic triple-negative breast cancer (TNBC) in a clinically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ccbc9a10eb6d0761509999c0ea9a4ed
https://doi.org/10.1158/1078-0432.c.6526784.v1
https://doi.org/10.1158/1078-0432.c.6526784.v1
Autor:
Ashley Cimino-Mathews, Sarah J. Wheelan, Ben H. Park, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, David Chu, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Daniel J. Zabransky, Christopher D. Gocke, Katie Beierl, Bracha Erlanger Avigdor
Purpose: Although most human cancers display a single histology, there are unusual cases where two or more distinct tissue types present within a primary tumor. One such example is metaplastic breast carcinoma, a rare but aggressive cancer with a het
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6375bf8d29e61d0805a0723f6253cbc3
https://doi.org/10.1158/1078-0432.c.6525186.v1
https://doi.org/10.1158/1078-0432.c.6525186.v1
Autor:
Rachel Schiff, C. Kent Osborne, Jorge S. Reis-Filho, Britta Weigelt, Joe W. Gray, Mothaffar F. Rimawi, Susan G. Hilsenbeck, Chad A. Shaw, Ben H. Park, Gary C. Chamness, Felipe C. Geyer, Chandandeep Nagi, Carolina Gutierrez, Kenneth L. Scott, Daniel J. Zabransky, Ian Waters, Mahitha Rajendran, Tamika Mitchell, Martin Shea, Sarmistha Nanda, Tao Wang, Alexander Renwick, Edward S. Chen, Charlotte K.Y. Ng, Nicholas Wang, Laura M. Heiser, Vidyalakshmi Sethunath, Jamunarani Veeraraghavan, Lanfang Qin, Huizhong Hu, Agostina Nardone, Kathleen A. Burke, Carmine De Angelis, Xiaowei Xu
Purpose: Resistance to anti-HER2 therapies in HER2+ breast cancer can occur through activation of alternative survival pathways or reactivation of the HER signaling network. Here we employed BT474 parental and treatment-resistant cell line models to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e201b57c505d629e55aa1001b1f5bfb
https://doi.org/10.1158/1078-0432.c.6526164.v1
https://doi.org/10.1158/1078-0432.c.6526164.v1